Skip to content

Clinical trials

Phase 3 Epilepsy trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Bulgaria Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20091
20104
20116
20122
20133
20142
20153
20161
20191
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.7
UCB BIOSCIENCES, Inc.5
UCB Pharma5
Xenon Pharmaceuticals Inc.4
GlaxoSmithKline2
Sumitomo Pharma America, Inc.2
UCB BIOSCIENCES GmbH2
Bial - Portela C S.A.1
Eisai Inc.1
Marinus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy32
Seizures15
Epilepsies, Partial5
Drug Resistant Epilepsy1
Epilepsy, Complex Partial1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.